Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
May 4 GTHX G1 Therapeutics, Inc. (NASDAQ:GTHX) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 3 GTHX G1 Therapeutics First Quarter 2024 Earnings: Revenues Disappoint
May 2 NKTR Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets
May 2 GTHX G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript
May 2 GTHX G1 Therapeutics Inc (GTHX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...
May 2 GTHX Q1 2024 G1 Therapeutics Inc Earnings Call
May 1 GTHX G1 Therapeutics, Inc. (GTHX) Q1 2024 Earnings Call Transcript
May 1 GTHX G1 Therapeutics and Pepper Bio sign license agreement for lerociclib
May 1 BNTC Benitec Biopharma to Participate in the Citizens JMP Life Science Conference
May 1 GTHX G1 Therapeutics Inc (GTHX) Q1 2024 Earnings: Close Alignment with Analyst Revenue Projections
May 1 GTHX G1 Therapeutics (GTHX) Reports Q1 Loss, Lags Revenue Estimates
May 1 GTHX G1 Therapeutics reports mixed Q1 results; reaffirms FY24 outlook
May 1 GTHX G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
May 1 GTHX G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
Apr 30 MACK Merrimack Pharmaceuticals announces notification of plan to delist common stock on Nasdaq
Apr 30 MACK Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution
Apr 30 GTHX G1 Therapeutics Q1 2024 Earnings Preview
Apr 29 OCS Oculis Publishes Invitation to the Annual General Meeting
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags